Skip to Content

AB Science ABSCF

Morningstar Rating
$2.70 −0.06 (2.33%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ABSCF is trading at a 435% premium.
Price
$2.71
Fair Value
$6.24
Uncertainty
Extreme
1-Star Price
$237.86
5-Star Price
$5.94
Economic Moat
Snrp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ABSCF is a good fit for your portfolio.

Trading Information

Previous Close Price
$2.76
Day Range
$2.702.70
52-Week Range
$0.004.46
Bid/Ask
$0.00 / $14.00
Market Cap
$133.71 Mil
Volume/Avg
1,452 / 33,201

Key Statistics

Price/Earnings (Normalized)
1.67
Price/Sales
175.43
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
53

Comparables

Valuation

Metric
ABSCF
IVA
ALVR
Price/Earnings (Normalized)
1.67
Price/Book Value
0.71
Price/Sales
175.437.20
Price/Cash Flow
Price/Earnings
ABSCF
IVA
ALVR

Financial Strength

Metric
ABSCF
IVA
ALVR
Quick Ratio
0.990.8518.38
Current Ratio
1.040.9618.48
Interest Coverage
−4.02−20.40
Quick Ratio
ABSCF
IVA
ALVR

Profitability

Metric
ABSCF
IVA
ALVR
Return on Assets (Normalized)
−35.12%−125.09%−52.15%
Return on Equity (Normalized)
−5,550.40%−65.46%
Return on Invested Capital (Normalized)
−275.68%−59.04%
Return on Assets
ABSCF
IVA
ALVR
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
KwvjqcfkjPfg$78.1 Bil
Merck KGaA ADR
MKKGY
FhvptpqpglHlyfhxw$77.8 Bil
Haleon PLC ADR
HLN
JldxqdgRtpfn$38.6 Bil
Viatris Inc
VTRS
DpqrndsvzMpc$12.5 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
BdmfccxlbKgpt$12.0 Bil
Catalent Inc
CTLT
HfkxpgzRmqrpc$10.2 Bil
Perrigo Co PLC
PRGO
LylghvgsKjsb$3.5 Bil
Prestige Consumer Healthcare Inc
PBH
McbtxkdvPdkbfw$3.5 Bil
Curaleaf Holdings Inc
CURLF
MwwbvjjnwHfxl$3.0 Bil
Green Thumb Industries Inc
GTBIF
ChzzzjvgvJdpfm$2.8 Bil

Sponsor Center